DURHAM, N.C. & SEATTLE--January 12, 2025--Leading epigenome editing company Tune Therapeutics (Tune) today announced the completion of over $175M in financing led by New Enterprise Associates, Yosemite, Regeneron Ventures and...
Art Pappas to sit on a panel titled "Venture Funding" at the EDC BioTech 2008 conference at in Miami, FL
News | 04. 24. 2008
© 2024 Pappas Capital, LLC. ALL RIGHTS RESERVED.